"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
(Generic versions may still be available.)
Patients should be instructed to promptly report the development of bruising or bleeding; any signs of infections such as fever, chills, sore throat, or soreness and ulcers in the mouth; any pulmonary symptoms, such as exertional dyspnea, cough, or wheezing; rash.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Tonocard Information
Report Problems to the Food and Drug Administration
Find out what women really need.